InvestorsObserver
Sign Up Login

TNDM Tandem Diabetes Care

$70.81 $0.00 (0.00%)
Add to Watchlist Compare
Overall

TNDM Stock Analysis Overview

What this means: InvestorsObserver gives Tandem Diabetes Care (TNDM) an overall rank of 46, which is below average. Tandem Diabetes Care is in the bottom half of stocks based on the fundamental outlook for the stock and an analysis of the stock's chart. A rank of 46 means that 54% of stocks appear more favorable to our system.

Who this matters to: Overall Ranking is a comprehensive evaluation. It considers technical and fundamental factors and is a good starting point for evaluating a stock.

View Sample Report
Fundamental PREMIUM

TNDM Fundamental Analysis

Who this matters to: The Fundamental Ranking considers the health of the underlying company. It is best used by longer-term buy-and-hold investors.

Upgrade to Premium to unlock Fundamental Ranking

Short-Term Technical PREMIUM

TNDM Short-Term Technical Analysis

Who this matters to: The Short-Term Technical Ranking evaluates a stock’s trading over the past month. This is most useful for short- to medium-term stock and option traders.

Upgrade to Premium to unlock Short-Term Technical Ranking

Long-Term Technical PREMIUM

TNDM Long-Term Technical Analysis

Who this matters to: The Long-Term Technical Ranking is a good gauge of how a stock has traded over the past several months. This is useful for medium to long-term stock and option traders.

Upgrade to Premium to unlock Long-Term Technical Ranking

Analyst Ranking PREMIUM

TNDM Analyst Ranking

Who this matters to: Analyst Ranking shows you which stocks Wall Street analysts like the most. Since analysts build valuation models, this is most useful for medium to long-term investors who are interested in a valuation-based approach.

Upgrade to Premium to unlock Analyst Ranking Analysis

Valuation PREMIUM

TNDM Valuation Ranking Analysis

Who this matters to: Valuation Ranking is most-useful for value-focused investors who plan to hold a stock for the long term.

Upgrade to Premium to unlock Valuation Ranking

Stock Sentiment PREMIUM

TNDM Stock Sentiment Analysis

Who this matters to: Sentiment Rank looks at the past five trading days. This is our shortest-term evaluation and is best used by people with a very short horizon.

Upgrade to Premium to unlock Stock Sentiment Ranking

TNDM Stock Analysis Overview

What this means: InvestorsObserver gives Tandem Diabetes Care (TNDM) an overall rank of 46, which is below average. Tandem Diabetes Care is in the bottom half of stocks based on the fundamental outlook for the stock and an analysis of the stock's chart. A rank of 46 means that 54% of stocks appear more favorable to our system.

Who this matters to: Overall Ranking is a comprehensive evaluation. It considers technical and fundamental factors and is a good starting point for evaluating a stock.

Create a FREE account to see full TNDM report

TNDM Fundamental Analysis

Who this matters to: The Fundamental Ranking considers the health of the underlying company. It is best used by longer-term buy-and-hold investors.

Upgrade to Premium to unlock Fundamental Ranking

TNDM Short-Term Technical Analysis

Who this matters to: The Short-Term Technical Ranking evaluates a stock’s trading over the past month. This is most useful for short- to medium-term stock and option traders.

Upgrade to Premium to unlock Short-Term Technical Ranking

TNDM Long-Term Technical Analysis

Who this matters to: The Long-Term Technical Ranking is a good gauge of how a stock has traded over the past several months. This is useful for medium to long-term stock and option traders.

Upgrade to Premium to unlock Long-Term Technical Ranking

TNDM Analyst Ranking

Who this matters to: Analyst Ranking shows you which stocks Wall Street analysts like the most. Since analysts build valuation models, this is most useful for medium to long-term investors who are interested in a valuation-based approach.

Upgrade to Premium to unlock Analyst Ranking Analysis

TNDM Valuation Ranking Analysis

Who this matters to: Valuation Ranking is most-useful for value-focused investors who plan to hold a stock for the long term.

Upgrade to Premium to unlock Valuation Ranking

TNDM Stock Sentiment Analysis

Who this matters to: Sentiment Rank looks at the past five trading days. This is our shortest-term evaluation and is best used by people with a very short horizon.

Upgrade to Premium to unlock Stock Sentiment Ranking

Tandem Diabetes Care (TNDM) Analyst Forecast

TNDM Price, Volume, Earnings, and Dividend Date

  • Last Price $70.81
  • Previous Close $70.81
  • Change $0.00
  • Open $69.02
  • Volume 1,224,200
  • Avg. Volume (100-day) 693,237
  • Market Cap 4,529,201,053
  • Days Range 68.275 - 71.68
  • 52-week Range 60.25 - 155.86
  • Dividend Yield —
  • Ex. Dividend Date —
  • P-E 748.6
  • EPS 0.090000003
  • Earnings Date 08/02/22
  • Sector Healthcare
  • Industry Medical Devices
  • Avg. Analyst Rec. Premium
  • Beta 1.757
  • PEG Ratio —

Tandem Diabetes Care (TNDM) Company Description

Tandem Diabetes Care Inc is a medical device company that develops products for people with insulin-dependent diabetes. The firm has three key insulin pump products. The t:slim Insulin Delivery System can easily fit into a user's pocket. The t:flex Insulin Delivery System is used by customers with greater insulin needs. The t:slim G4 Insulin Delivery system is a continuous glucose monitoring enabled pump with a touch screen. Tandem Diabetes also sells pump-related supplies and accessories. Pump sales contribute the majority of revenue. The firm generates virtually all of its revenue in the United States.

Tandem Diabetes Care (TNDM) Stock Chart

View Interactive TNDM chart

My Watchlists

Follow Your Favorite Stocks

Top Stocks in Medical Devices

Company Price
Aethlon Medical (AEMD) (AEMD) $1.47
Sensus Healthcare Inc (SRTS) (SRTS) $8.96
Brainsway Ltd ADR (BWAY) (BWAY) $7.10
Edap Tms Sa ADR (EDAP) (EDAP) $7.10
Nano-X Imaging Ltd (NNOX) (NNOX) $10.38
Beyond Air Inc (XAIR) (XAIR) $5.75
Establishment Labs Holdings Inc (ESTA) (ESTA) $62.85
Neovasc Inc (NVCN) (NVCN) $5.78
Axonics Inc (AXNX) (AXNX) $52.33
Viemed Healthcare Inc (VMD) (VMD) $5.81